PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AGRX vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between AGRX and SPY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

AGRX vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Agile Therapeutics, Inc. (AGRX) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-2.00%0.00%2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February0
10.70%
AGRX
SPY

Key characteristics

Sharpe Ratio

AGRX:

-0.18

SPY:

1.97

Sortino Ratio

AGRX:

1.77

SPY:

2.64

Omega Ratio

AGRX:

1.42

SPY:

1.36

Calmar Ratio

AGRX:

-0.62

SPY:

2.97

Martin Ratio

AGRX:

-1.04

SPY:

12.34

Ulcer Index

AGRX:

59.44%

SPY:

2.03%

Daily Std Dev

AGRX:

347.28%

SPY:

12.68%

Max Drawdown

AGRX:

-100.00%

SPY:

-55.19%

Current Drawdown

AGRX:

-100.00%

SPY:

-0.01%

Returns By Period

Over the past 10 years, AGRX has underperformed SPY with an annualized return of -64.72%, while SPY has yielded a comparatively higher 13.22% annualized return.


AGRX

YTD

0.00%

1M

0.00%

6M

-58.75%

1Y

-50.74%

5Y*

-85.42%

10Y*

-64.72%

SPY

YTD

4.03%

1M

2.85%

6M

10.70%

1Y

23.01%

5Y*

14.30%

10Y*

13.22%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AGRX vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AGRX
The Risk-Adjusted Performance Rank of AGRX is 4747
Overall Rank
The Sharpe Ratio Rank of AGRX is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of AGRX is 7575
Sortino Ratio Rank
The Omega Ratio Rank of AGRX is 9292
Omega Ratio Rank
The Calmar Ratio Rank of AGRX is 1111
Calmar Ratio Rank
The Martin Ratio Rank of AGRX is 2121
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7979
Overall Rank
The Sharpe Ratio Rank of SPY is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7676
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7979
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 8080
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AGRX vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Agile Therapeutics, Inc. (AGRX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AGRX, currently valued at -0.14, compared to the broader market-2.000.002.004.00-0.141.97
The chart of Sortino ratio for AGRX, currently valued at 2.11, compared to the broader market-6.00-4.00-2.000.002.004.006.002.112.64
The chart of Omega ratio for AGRX, currently valued at 1.54, compared to the broader market0.501.001.502.001.541.36
The chart of Calmar ratio for AGRX, currently valued at -0.50, compared to the broader market0.002.004.006.00-0.502.97
The chart of Martin ratio for AGRX, currently valued at -0.90, compared to the broader market-10.000.0010.0020.0030.00-0.9012.34
AGRX
SPY

The current AGRX Sharpe Ratio is -0.18, which is lower than the SPY Sharpe Ratio of 1.97. The chart below compares the historical Sharpe Ratios of AGRX and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.14
1.97
AGRX
SPY

Dividends

AGRX vs. SPY - Dividend Comparison

AGRX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.16%.


TTM20242023202220212020201920182017201620152014
AGRX
Agile Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.16%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

AGRX vs. SPY - Drawdown Comparison

The maximum AGRX drawdown since its inception was -100.00%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for AGRX and SPY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-100.00%
-0.01%
AGRX
SPY

Volatility

AGRX vs. SPY - Volatility Comparison

The current volatility for Agile Therapeutics, Inc. (AGRX) is 0.00%, while SPDR S&P 500 ETF (SPY) has a volatility of 3.15%. This indicates that AGRX experiences smaller price fluctuations and is considered to be less risky than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February0
3.15%
AGRX
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab